Multiple inlet sudden expansion flow of power-law fluids

The flow of power-law fluids through two-dimensional planar sudden expansion geometries with multiple inlets was simulated numerically using an in-house finite volume code. The fluids are modelled using the power-law model, and a range of power-law index values (0.4 ≤ n ≤ 1.4) was investigated to cover shear-thinning, Newtonian and shear-thickening inelastic behaviour. The effect of the generalised Reynolds number and the spacing between inlets on the flow behaviour and stability was analysed. The main characteristics of the vortices formed near the wall are similar to those found in single inlet sudden expansions, with symmetric wall vortices forming at low Reynolds numbers, with transitions to steady asymmetric, third eddy flow regimes and time-dependent flow at higher generalised Reynolds numbers. In some cases, the steady asymmetric and third eddy regimes are absent and the flow transitions directly from symmetric flow to time dependent flow (as seen for the geometry with the largest spacing). The stabilising nature of shear-thinning behaviour was observed and the opposite effect was seen for shear-thickening behaviour. In addition, intermediate vortices were seen to form between inlets which grow in size within the symmetric regime as the generalised Reynolds number is increased. New scalings which help collapse the data are introduced and a strong effect of inlet spacing on all flow transitions is shown, with the ratio of the wall distance to inlet height being a determining factor on the corner vortices length when the spacing between inlets is sufficiently large

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute respiratory failure or shock and hypoactive or hyperactive delirium to receive intravenous boluses of haloperidol (maximum dose, 20 mg daily), ziprasidone (maximum dose, 40 mg daily), or placebo. The volume and dose of a trial drug or placebo was halved or doubled at 12-hour intervals on the basis of the presence or absence of delirium, as detected with the use of the Confusion Assessment Method for the ICU, and of side effects of the intervention. The primary end point was the number of days alive without delirium or coma during the 14-day intervention period. Secondary end points included 30-day and 90-day survival, time to freedom from mechanical ventilation, and time to ICU and hospital discharge. Safety end points included extrapyramidal symptoms and excessive sedation. RESULTS: Written informed consent was obtained from 1183 patients or their authorized representatives. Delirium developed in 566 patients (48%), of whom 89% had hypoactive delirium and 11% had hyperactive delirium. Of the 566 patients, 184 were randomly assigned to receive placebo, 192 to receive haloperidol, and 190 to receive ziprasidone. The median duration of exposure to a trial drug or placebo was 4 days (interquartile range, 3 to 7). The median number of days alive without delirium or coma was 8.5 (95% confidence interval [CI], 5.6 to 9.9) in the placebo group, 7.9 (95% CI, 4.4 to 9.6) in the haloperidol group, and 8.7 (95% CI, 5.9 to 10.0) in the ziprasidone group (P=0.26 for overall effect across trial groups). The use of haloperidol or ziprasidone, as compared with placebo, had no significant effect on the primary end point (odds ratios, 0.88 [95% CI, 0.64 to 1.21] and 1.04 [95% CI, 0.73 to 1.48], respectively). There were no significant between-group differences with respect to the secondary end points or the frequency of extrapyramidal symptoms. CONCLUSIONS: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the ICU did not significantly alter the duration of delirium. (Funded by the National Institutes of Health and the VA Geriatric Research Education and Clinical Center; MIND-USA ClinicalTrials.gov number, NCT01211522 .)

One-loop corrections to the metastable vacuum decay

We evaluate the one-loop prefactor in the false vacuum decay rate in a theory of a self interacting scalar field in 3+1 dimensions. We use a numerical method, established some time ago, which is based on a well-known theorem on functional determinants. The proper handling of zero modes and of renormalization is discussed. The numerical results in particular show that quantum corrections become smaller away from the thin-wall case. In the thin-wall limit the numerical results are found to join into those obtained by a gradient expansion.Comment: 31 pages, 7 figure

Computation of the winding number diffusion rate due to the cosmological sphaleron

A detailed quantitative analysis of the transition process mediated by a sphaleron type non-Abelian gauge field configuration in a static Einstein universe is carried out. By examining spectra of the fluctuation operators and applying the zeta function regularization scheme, a closed analytical expression for the transition rate at the one-loop level is derived. This is a unique example of an exact solution for a sphaleron model in $3+1$ spacetime dimensions.Comment: Some style corrections suggested by the referee are introduced (mainly in Sec.II), one reference added. To appear in Phys.Rev.D 29 pages, LaTeX, 3 Postscript figures, uses epsf.st

AgBioData consortium recommendations for sustainable genomics and genetics databases for agriculture

The future of agricultural research depends on data. The sheer volume of agricultural biological data being produced today makes excellent data management essential. Governmental agencies, publishers and science funders require data management plans for publicly funded research. Furthermore, the value of data increases exponentially when they are properly stored, described, integrated and shared, so that they can be easily utilized in future analyses. AgBioData (https://www.agbiodata.org) is a consortium of people working at agricultural biological databases, data archives and knowledgbases who strive to identify common issues in database development, curation and management, with the goal of creating database products that are more Findable, Accessible, Interoperable and Reusable. We strive to promote authentic, detailed, accurate and explicit communication between all parties involved in scientific data. As a step toward this goal, we present the current state of biocuration, ontologies, metadata and persistence, database platforms, programmatic (machine) access to data, communication and sustainability with regard to data curation. Each section describes challenges and opportunities for these topics, along with recommendations and best practices

Rare genetic variants explain missing heritability in smoking

Common genetic variants explain less variation in complex phenotypes than inferred from family-based studies, and there is a debate on the source of this ‘missing heritability’. We investigated the contribution of rare genetic variants to tobacco use with whole-genome sequences from up to 26,257 unrelated individuals of European ancestries and 11,743 individuals of African ancestries. Across four smoking traits, single-nucleotide-polymorphism-based heritability (hSNP2) was estimated from 0.13 to 0.28 (s.e., 0.10–0.13) in European ancestries, with 35–74% of it attributable to rare variants with minor allele frequencies between 0.01% and 1%. These heritability estimates are 1.5–4 times higher than past estimates based on common variants alone and accounted for 60% to 100% of our pedigree-based estimates of narrow-sense heritability (hped2, 0.18–0.34). In the African ancestry samples, hSNP2 was estimated from 0.03 to 0.33 (s.e., 0.09–0.14) across the four smoking traits. These results suggest that rare variants are important contributors to the heritability of smoking

Dielectrophoretic Characterization of SnO2 Nanobelts

In the present work we report the results of AC dielectrophoresis experiments on ethanol suspended SnO2 nanobelts. AC field (frequency - 5 Hz - 10 MHz) was applied between microelectrodes, and detailed and direct observations of the nanobelt motion were performed. It revealed a wide variety of nanobelt motions induced by the dielectrophoretic forces, which include attraction and repulsion depending on the signal frequency range. These forces caused rigid body motion and deformation in long nanobelts, and pearl chain formation in short nanobelts and particles. The presence of negative (repulsion) dielectrophoresis is unusual in SnO2, since bulk material properties dictate positive dielectrophorsis in the frequency range studied